Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Equity (2016 - 2025)

Historic Return on Equity for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.55%.

  • CorMedix's Return on Equity rose 13300.0% to 0.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55%, marking a year-over-year increase of 13300.0%. This contributed to the annual value of 0.5% for FY2022, which is 200.0% up from last year.
  • Latest data reveals that CorMedix reported Return on Equity of 0.55% as of Q3 2025, which was up 13300.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, CorMedix's Return on Equity ranged from a high of 0.55% in Q3 2025 and a low of 0.95% during Q2 2024
  • Moreover, its 5-year median value for Return on Equity was 0.48% (2022), whereas its average is 0.39%.
  • As far as peak fluctuations go, CorMedix's Return on Equity tumbled by -2400bps in 2024, and later surged by 13300bps in 2025.
  • Over the past 5 years, CorMedix's Return on Equity (Quarter) stood at 0.43% in 2021, then fell by -25bps to 0.53% in 2022, then fell by -13bps to 0.6% in 2023, then skyrocketed by 58bps to 0.25% in 2024, then surged by 318bps to 0.55% in 2025.
  • Its Return on Equity stands at 0.55% for Q3 2025, versus 0.3% for Q2 2025 and 0.17% for Q1 2025.